nodes	percent_of_prediction	percent_of_DWPC	metapath
Olsalazine—IFNG—cardiovascular system—attention deficit hyperactivity disorder	0.0798	0.104	CbGeAlD
Olsalazine—IFNG—nervous system—attention deficit hyperactivity disorder	0.0512	0.0669	CbGeAlD
Olsalazine—IFNG—central nervous system—attention deficit hyperactivity disorder	0.0493	0.0644	CbGeAlD
Olsalazine—TPMT—Methylation Pathways—COMT—attention deficit hyperactivity disorder	0.0478	0.204	CbGpPWpGaD
Olsalazine—TPMT—Methylation—COMT—attention deficit hyperactivity disorder	0.0439	0.188	CbGpPWpGaD
Olsalazine—ALOX5—cardiovascular system—attention deficit hyperactivity disorder	0.0405	0.0529	CbGeAlD
Olsalazine—IFNG—brain—attention deficit hyperactivity disorder	0.0392	0.0511	CbGeAlD
Olsalazine—PPARG—forebrain—attention deficit hyperactivity disorder	0.036	0.047	CbGeAlD
Olsalazine—TPMT—midbrain—attention deficit hyperactivity disorder	0.0359	0.0469	CbGeAlD
Olsalazine—PPARG—cardiovascular system—attention deficit hyperactivity disorder	0.0304	0.0397	CbGeAlD
Olsalazine—TPMT—nervous system—attention deficit hyperactivity disorder	0.0295	0.0385	CbGeAlD
Olsalazine—TPMT—central nervous system—attention deficit hyperactivity disorder	0.0284	0.0371	CbGeAlD
Olsalazine—TPMT—cerebellum—attention deficit hyperactivity disorder	0.0278	0.0363	CbGeAlD
Olsalazine—ALOX5—nervous system—attention deficit hyperactivity disorder	0.026	0.034	CbGeAlD
Olsalazine—ALOX5—central nervous system—attention deficit hyperactivity disorder	0.025	0.0327	CbGeAlD
Olsalazine—ALOX5—cerebellum—attention deficit hyperactivity disorder	0.0245	0.032	CbGeAlD
Olsalazine—TPMT—brain—attention deficit hyperactivity disorder	0.0226	0.0294	CbGeAlD
Olsalazine—ALOX5—brain—attention deficit hyperactivity disorder	0.0199	0.026	CbGeAlD
Olsalazine—PPARG—nervous system—attention deficit hyperactivity disorder	0.0195	0.0255	CbGeAlD
Olsalazine—PTGS1—forebrain—attention deficit hyperactivity disorder	0.0192	0.0251	CbGeAlD
Olsalazine—PPARG—central nervous system—attention deficit hyperactivity disorder	0.0188	0.0245	CbGeAlD
Olsalazine—PTGS2—forebrain—attention deficit hyperactivity disorder	0.0184	0.024	CbGeAlD
Olsalazine—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.0163	0.0212	CbGeAlD
Olsalazine—PTGS2—cardiovascular system—attention deficit hyperactivity disorder	0.0155	0.0203	CbGeAlD
Olsalazine—PPARG—brain—attention deficit hyperactivity disorder	0.0149	0.0195	CbGeAlD
Olsalazine—PTGS2—midbrain—attention deficit hyperactivity disorder	0.0121	0.0158	CbGeAlD
Olsalazine—IFNG—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.011	0.0469	CbGpPWpGaD
Olsalazine—PTGS1—nervous system—attention deficit hyperactivity disorder	0.0104	0.0136	CbGeAlD
Olsalazine—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.0101	0.0131	CbGeAlD
Olsalazine—PTGS2—nervous system—attention deficit hyperactivity disorder	0.00998	0.013	CbGeAlD
Olsalazine—PTGS2—central nervous system—attention deficit hyperactivity disorder	0.00961	0.0125	CbGeAlD
Olsalazine—PTGS2—cerebellum—attention deficit hyperactivity disorder	0.00939	0.0123	CbGeAlD
Olsalazine—IFNG—SHP2 signaling—BDNF—attention deficit hyperactivity disorder	0.00809	0.0345	CbGpPWpGaD
Olsalazine—PTGS1—brain—attention deficit hyperactivity disorder	0.00798	0.0104	CbGeAlD
Olsalazine—TPMT—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00771	0.0329	CbGpPWpGaD
Olsalazine—PTGS2—brain—attention deficit hyperactivity disorder	0.00763	0.00996	CbGeAlD
Olsalazine—IFNG—IFN-gamma pathway—EP300—attention deficit hyperactivity disorder	0.0046	0.0196	CbGpPWpGaD
Olsalazine—IFNG—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00458	0.0196	CbGpPWpGaD
Olsalazine—TPMT—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00451	0.0193	CbGpPWpGaD
Olsalazine—TPMT—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00448	0.0191	CbGpPWpGaD
Olsalazine—TPMT—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00445	0.019	CbGpPWpGaD
Olsalazine—IFNG—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00436	0.0186	CbGpPWpGaD
Olsalazine—IFNG—TGF-beta Receptor Signaling—EP300—attention deficit hyperactivity disorder	0.00384	0.0164	CbGpPWpGaD
Olsalazine—IFNG—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00357	0.0153	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00315	0.0135	CbGpPWpGaD
Olsalazine—IFNG—AP-1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00312	0.0133	CbGpPWpGaD
Olsalazine—IFNG—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.00275	0.0117	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00266	0.0114	CbGpPWpGaD
Olsalazine—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00239	0.0102	CbGpPWpGaD
Olsalazine—IFNG—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00225	0.00961	CbGpPWpGaD
Olsalazine—IFNG—Immune System—STUB1—attention deficit hyperactivity disorder	0.00218	0.0093	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00213	0.00909	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00213	0.00909	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00206	0.0088	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.002	0.00854	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00186	0.00796	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00184	0.00788	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00184	0.00786	CbGpPWpGaD
Olsalazine—PPARG—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.00169	0.0072	CbGpPWpGaD
Olsalazine—IFNG—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00165	0.00705	CbGpPWpGaD
Olsalazine—PPARG—Signaling events mediated by HDAC Class I—EP300—attention deficit hyperactivity disorder	0.00161	0.00687	CbGpPWpGaD
Olsalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—attention deficit hyperactivity disorder	0.00149	0.00636	CbGpPWpGaD
Olsalazine—PTGS2—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00132	0.00562	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00554	CbGpPWpGaD
Olsalazine—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00128	0.00546	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00127	0.00544	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00127	0.00544	CbGpPWpGaD
Olsalazine—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00127	0.00543	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00125	0.00535	CbGpPWpGaD
Olsalazine—PTGS2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00125	0.00534	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00121	0.00515	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00119	0.00506	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00116	0.00497	CbGpPWpGaD
Olsalazine—PPARG—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.00112	0.00478	CbGpPWpGaD
Olsalazine—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.0011	0.00468	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00102	0.00435	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000969	0.00414	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000895	0.00382	CbGpPWpGaD
Olsalazine—PPARG—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000847	0.00362	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000833	0.00356	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000833	0.00356	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00082	0.0035	CbGpPWpGaD
Olsalazine—PTGS2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000773	0.0033	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—COMT—attention deficit hyperactivity disorder	0.000771	0.00329	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000766	0.00327	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000762	0.00325	CbGpPWpGaD
Olsalazine—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000755	0.00323	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000747	0.00319	CbGpPWpGaD
Olsalazine—PPARG—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000692	0.00295	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000666	0.00284	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000634	0.00271	CbGpPWpGaD
Olsalazine—PTGS2—Disease—STUB1—attention deficit hyperactivity disorder	0.000577	0.00247	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000523	0.00223	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000516	0.0022	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000516	0.0022	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000507	0.00217	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000505	0.00215	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000501	0.00214	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000486	0.00207	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000472	0.00201	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000415	0.00177	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000412	0.00176	CbGpPWpGaD
Olsalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000401	0.00171	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000392	0.00168	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000361	0.00154	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000361	0.00154	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000355	0.00152	CbGpPWpGaD
Olsalazine—PPARG—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000337	0.00144	CbGpPWpGaD
Olsalazine—IFNG—Immune System—EP300—attention deficit hyperactivity disorder	0.000336	0.00143	CbGpPWpGaD
Olsalazine—TPMT—Metabolism—EP300—attention deficit hyperactivity disorder	0.000331	0.00141	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00033	0.00141	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—COMT—attention deficit hyperactivity disorder	0.000312	0.00133	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00031	0.00132	CbGpPWpGaD
Olsalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000301	0.00128	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000289	0.00123	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000287	0.00122	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000287	0.00122	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000282	0.0012	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000275	0.00117	CbGpPWpGaD
Olsalazine—PTGS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000274	0.00117	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000262	0.00112	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000229	0.000979	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000219	0.000934	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000218	0.000932	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000217	0.000928	CbGpPWpGaD
Olsalazine—ALOX5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000216	0.000924	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000211	0.0009	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000174	0.000742	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000173	0.000737	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000167	0.000714	CbGpPWpGaD
Olsalazine—PPARG—Metabolism—EP300—attention deficit hyperactivity disorder	0.000134	0.000572	CbGpPWpGaD
Olsalazine—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	9.38e-05	0.000401	CbGpPWpGaD
Olsalazine—PTGS2—Disease—EP300—attention deficit hyperactivity disorder	8.9e-05	0.00038	CbGpPWpGaD
Olsalazine—PTGS2—Metabolism—EP300—attention deficit hyperactivity disorder	7.45e-05	0.000318	CbGpPWpGaD
